US healthcare conglomerate UnitedHealth has exited Latin America with the sale of its last subsidiary in the region, hospital chain Empresas Banmedica, to Latino private equity firm Patria Investments.
Kidney dialysis services provider DaVita is going to become the largest dialysis services provider in Latin America following agreements with Fresenius Medical Care, a rival multinational group, to expand in Brazil and Colombia and enter Chile and Ecuador for the first time.
Healthcare conglomerate Fresenius has sold Eugin, its Spain-based fertility business, to KKR-owned fertility group IVI RMA and Spain-based asset management firm GED for €500m including earn-outs.
Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion.
Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.
Abu Dhabi sovereign wealth fund Mubadala Investment Co is considering the acquisition of $2.5bn Swedish pan-European dialysis group Diaverum, according to reports.
This week, HBI looks at the annual inflow of nurses from abroad to the big five Western European markets - the United Kingdom, Germany, France, Italy, and Spain - using public data from OECD. Those looking for an outlier need look no further than the UK.
Facing an increasingly volatile market, American buyout / investment firm KKR may switch to direct lenders to finance its acquisition of fertility company IVI RMA Global, despite agreeing €800m of underwritten financing from four investment banks.
Multiple sources say US-based buyout specialist KKR is close to closing a deal to buy Spain-based global fertility player IVI-RMA, the largest group in the sector by revenue.
Five major private health insurers in Chile saw record losses in 2021, collectively worth $137bn. The losses ‘put the entire private health system at risk’, according to private health insurers’ representative body the Association of Isapres.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
